Global Patient Derived Xenograft Models Market Research Report 2021
Global Patient Derived Xenograft Models Market Research Report 2021
The Patient Derived Xenograft Models Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Patient Derived Xenograft Models Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Patient Derived Xenograft Models Market Overview:
Global Patient Derived Xenograft Models Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Patient Derived Xenograft Models involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Patient Derived Xenograft Models Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Patient Derived Xenograft Models market in 2020.
Global Patient Derived Xenograft Models Market Segmentation
By Type, Patient Derived Xenograft Models market has been segmented into:
Mice Models
Rat Models
By Application, Patient Derived Xenograft Models market has been segmented into:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Patient Derived Xenograft Models market are:
Crown Bioscience Inc. (US)
WuXi AppTec (China)
Champions Oncology Inc. (US)
The Jackson Laboratory (US)
ONCODESIGN (France)
Charles River Laboratories International Inc. (US)
EPO Berlin-Buch GmBH (Germany)
Shanghai LIDE Biotech Co. Ltd (China)
Xentech (France)
Horizon Discovery Group PLC (UK)
Urolead (France)
Explora BioLabs (US)
1. Market Overview of Patient Derived Xenograft Models
1.1 Patient Derived Xenograft Models Market Overview
1.1.1 Patient Derived Xenograft Models Product Scope
1.1.2 Market Status and Outlook
1.2 Patient Derived Xenograft Models Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Patient Derived Xenograft Models Historic Market Size by Regions (2015-2020)
1.4 Patient Derived Xenograft Models Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Patient Derived Xenograft Models Sales Market by Type (2015-2026)
2.1 Global Patient Derived Xenograft Models Historic Market Size by Type (2015-2020)
2.2 Global Patient Derived Xenograft Models Forecasted Market Size by Type (2021-2026)
2.3 Mice Models
2.4 Rat Models
3. Covid-19 Impact Patient Derived Xenograft Models Sales Market by Application (2015-2026)
3.1 Global Patient Derived Xenograft Models Historic Market Size by Application (2015-2020)
3.2 Global Patient Derived Xenograft Models Forecasted Market Size by Application (2021-2026)
3.3 Pharmaceutical & Biotechnology Companies
3.4 Contract Research Organizations
3.5 Academic & Research Institutions
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Patient Derived Xenograft Models Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Patient Derived Xenograft Models Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Patient Derived Xenograft Models Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Patient Derived Xenograft Models Business
5.1 Crown Bioscience Inc. (US)
5.1.1 Crown Bioscience Inc. (US) Company Profile
5.1.2 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Specification
5.1.3 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 WuXi AppTec (China)
5.2.1 WuXi AppTec (China) Company Profile
5.2.2 WuXi AppTec (China) Patient Derived Xenograft Models Product Specification
5.2.3 WuXi AppTec (China) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Champions Oncology Inc. (US)
5.3.1 Champions Oncology Inc. (US) Company Profile
5.3.2 Champions Oncology Inc. (US) Patient Derived Xenograft Models Product Specification
5.3.3 Champions Oncology Inc. (US) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 The Jackson Laboratory (US)
5.4.1 The Jackson Laboratory (US) Company Profile
5.4.2 The Jackson Laboratory (US) Patient Derived Xenograft Models Product Specification
5.4.3 The Jackson Laboratory (US) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 ONCODESIGN (France)
5.5.1 ONCODESIGN (France) Company Profile
5.5.2 ONCODESIGN (France) Patient Derived Xenograft Models Product Specification
5.5.3 ONCODESIGN (France) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Charles River Laboratories International Inc. (US)
5.6.1 Charles River Laboratories International Inc. (US) Company Profile
5.6.2 Charles River Laboratories International Inc. (US) Patient Derived Xenograft Models Product Specification
5.6.3 Charles River Laboratories International Inc. (US) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 EPO Berlin-Buch GmBH (Germany)
5.7.1 EPO Berlin-Buch GmBH (Germany) Company Profile
5.7.2 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Specification
5.7.3 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Shanghai LIDE Biotech Co. Ltd (China)
5.8.1 Shanghai LIDE Biotech Co. Ltd (China) Company Profile
5.8.2 Shanghai LIDE Biotech Co. Ltd (China) Patient Derived Xenograft Models Product Specification
5.8.3 Shanghai LIDE Biotech Co. Ltd (China) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Xentech (France)
5.9.1 Xentech (France) Company Profile
5.9.2 Xentech (France) Patient Derived Xenograft Models Product Specification
5.9.3 Xentech (France) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Horizon Discovery Group PLC (UK)
5.10.1 Horizon Discovery Group PLC (UK) Company Profile
5.10.2 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Specification
5.10.3 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Urolead (France)
5.11.1 Urolead (France) Company Profile
5.11.2 Urolead (France) Patient Derived Xenograft Models Product Specification
5.11.3 Urolead (France) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Explora BioLabs (US)
5.12.1 Explora BioLabs (US) Company Profile
5.12.2 Explora BioLabs (US) Patient Derived Xenograft Models Product Specification
5.12.3 Explora BioLabs (US) Patient Derived Xenograft Models Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Patient Derived Xenograft Models Market Size (2015-2026)
6.2 North America Patient Derived Xenograft Models Key Players in North America (2015-2020)
6.3 North America Patient Derived Xenograft Models Market Size by Type (2015-2020)
6.4 North America Patient Derived Xenograft Models Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Patient Derived Xenograft Models Market Size (2015-2026)
7.2 East Asia Patient Derived Xenograft Models Key Players in North America (2015-2020)
7.3 East Asia Patient Derived Xenograft Models Market Size by Type (2015-2020)
7.4 East Asia Patient Derived Xenograft Models Market Size by Application (2015-2020)
8. Europe
8.1 Europe Patient Derived Xenograft Models Market Size (2015-2026)
8.2 Europe Patient Derived Xenograft Models Key Players in North America (2015-2020)
8.3 Europe Patient Derived Xenograft Models Market Size by Type (2015-2020)
8.4 Europe Patient Derived Xenograft Models Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Patient Derived Xenograft Models Market Size (2015-2026)
9.2 South Asia Patient Derived Xenograft Models Key Players in North America (2015-2020)
9.3 South Asia Patient Derived Xenograft Models Market Size by Type (2015-2020)
9.4 South Asia Patient Derived Xenograft Models Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Patient Derived Xenograft Models Market Size (2015-2026)
10.2 Southeast Asia Patient Derived Xenograft Models Key Players in North America (2015-2020)
10.3 Southeast Asia Patient Derived Xenograft Models Market Size by Type (2015-2020)
10.4 Southeast Asia Patient Derived Xenograft Models Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Patient Derived Xenograft Models Market Size (2015-2026)
11.2 Middle East Patient Derived Xenograft Models Key Players in North America (2015-2020)
11.3 Middle East Patient Derived Xenograft Models Market Size by Type (2015-2020)
11.4 Middle East Patient Derived Xenograft Models Market Size by Application (2015-2020)
12. Africa
12.1 Africa Patient Derived Xenograft Models Market Size (2015-2026)
12.2 Africa Patient Derived Xenograft Models Key Players in North America (2015-2020)
12.3 Africa Patient Derived Xenograft Models Market Size by Type (2015-2020)
12.4 Africa Patient Derived Xenograft Models Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Patient Derived Xenograft Models Market Size (2015-2026)
13.2 Oceania Patient Derived Xenograft Models Key Players in North America (2015-2020)
13.3 Oceania Patient Derived Xenograft Models Market Size by Type (2015-2020)
13.4 Oceania Patient Derived Xenograft Models Market Size by Application (2015-2020)
14. South America
14.1 South America Patient Derived Xenograft Models Market Size (2015-2026)
14.2 South America Patient Derived Xenograft Models Key Players in North America (2015-2020)
14.3 South America Patient Derived Xenograft Models Market Size by Type (2015-2020)
14.4 South America Patient Derived Xenograft Models Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Patient Derived Xenograft Models Market Size (2015-2026)
15.2 Rest of the World Patient Derived Xenograft Models Key Players in North America (2015-2020)
15.3 Rest of the World Patient Derived Xenograft Models Market Size by Type (2015-2020)
15.4 Rest of the World Patient Derived Xenograft Models Market Size by Application (2015-2020)
16 Patient Derived Xenograft Models Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Patient Derived Xenograft Models Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|